Paul Voss

Paul Voss currently serves as Vice President of Value, Access & Patient Services at Rezolute, Inc., focusing on ultra-rare pediatric endocrinology related to hyperinsulinism. In addition, Paul holds the role of Principal Consultant at Osprey BioPharma Strategies, LLC., providing expertise in product launch and market access strategies for emerging biopharmaceutical companies. Previously, Paul held vice president positions in market access and policy at Reneo Pharmaceuticals and Marinus Pharma, as well as serving as Executive Director for market access and reimbursement at Ionis Pharmaceuticals, specializing in ultra-rare diseases. Paul earned two Bachelor of Science degrees from Oregon State University.